You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 106 No. 1, January 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Subretinal neovascularization in a pseudophakic eye treated with krypton laser photocoagulation. A clinicopathologic case report

H. E. Grossniklaus, K. E. Frank and W. R. Green
Division of Ophthalmology, University Hospitals of Cleveland, Case Western Reserve University, OH.

A 76-year-old myopic woman who had undergone bilateral extracapsular cataract extractions and received posterior intraocular lens implants underwent two sessions of krypton laser photocoagulation for subretinal neovascularization secondary to age-related macular degeneration in her right eye. The patient expired and histopathologic examination of her treated eye showed a posterior chamber intraocular lens with both haptics in the ciliary sulcus, areas of macular degeneration, evidence of krypton laser photocoagulation including a full-thickness retinal scar, and an area of clinically unsuspected subretinal neovascularization.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Correlation of Histologic 2-Dimensional Reconstruction and Confocal Scanning Laser Microscopic Imaging of Choroidal Neovascularization in Eyes With Age-Related Maculopathy
Grossniklaus et al.
Arch Ophthalmol 2000;118:625-629.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.